[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 986 Reported in House (RH)]

<DOC>





                                                  Union Calendar No. 22
116th CONGRESS
  1st Session
                                H. R. 986

                      [Report No. 116-44, Part I]

     To provide that certain guidance related to waivers for State 
 innovation under the Patient Protection and Affordable Care Act shall 
                        have no force or effect.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            February 6, 2019

Ms. Kuster of New Hampshire (for herself, Mr. Beyer, and Mr. Courtney) 
 introduced the following bill; which was referred to the Committee on 
   Energy and Commerce, and in addition to the Committee on Ways and 
 Means, for a period to be subsequently determined by the Speaker, in 
   each case for consideration of such provisions as fall within the 
                jurisdiction of the committee concerned

                             April 30, 2019

Additional sponsors: Mr. Welch, Ms. Schakowsky, Ms. Castor of Florida, 
 Mr. Golden, Ms. Blunt Rochester, Mrs. Dingell, Mr. Kennedy, Mr. Rush, 
Mr. Ruiz, Mr. Pallone, Ms. Eshoo, Ms. Matsui, Mr. Van Drew, Ms. Clarke 
    of New York, Ms. McCollum, Mr. Schrader, and Ms. Mucarsel-Powell

                             April 30, 2019

           Reported from the Committee on Energy and Commerce

                             April 30, 2019

 Committee on Ways and Means discharged; committed to the Committee of 
  the Whole House on the State of the Union and ordered to be printed


_______________________________________________________________________

                                 A BILL


 
     To provide that certain guidance related to waivers for State 
 innovation under the Patient Protection and Affordable Care Act shall 
                        have no force or effect.


 


    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Protecting Americans with 
Preexisting Conditions Act of 2019''.

SEC. 2. PROVIDING THAT CERTAIN GUIDANCE RELATED TO WAIVERS FOR STATE 
              INNOVATION UNDER THE PATIENT PROTECTION AND AFFORDABLE 
              CARE ACT SHALL HAVE NO FORCE OR EFFECT.

    Beginning April 1, 2019, the Secretary of Health and Human Services 
and the Secretary of the Treasury may not take any action to implement, 
enforce, or otherwise give effect to the guidance entitled ``State 
Relief and Empowerment Waivers'' (83 Fed. Reg. 53575 (October 24, 
2018)), and the Secretaries may not promulgate any substantially 
similar guidance or rule.
                                                  Union Calendar No. 22

116th CONGRESS

  1st Session

                               H. R. 986

                      [Report No. 116-44, Part I]

_______________________________________________________________________

                                 A BILL

     To provide that certain guidance related to waivers for State 
 innovation under the Patient Protection and Affordable Care Act shall 
                        have no force or effect.

_______________________________________________________________________

                             April 30, 2019

           Reported from the Committee on Energy and Commerce

                             April 30, 2019

 Committee on Ways and Means discharged; committed to the Committee of 
  the Whole House on the State of the Union and ordered to be printed